BIOTHERAPEUTICS

Introduction

The Biotherapeutics Committee works together to increase global access to critical protein-based therapies by encouraging science-based solutions and supporting access to venues where scientists can meet and discuss challenges and potential opportunities for global alignment.

Goals & Objectives

Identify and provide opportunities for researchers, industry, and regulators to address long standing and emerging issues which affect global access to biotherapeutics.

Provide organizational support for meetings where leaders can openly discuss challenges and share information, leading to potential solutions or sparking
innovation.

Engage leaders working in the biopharmaceutical field and health care such that the paths to achieve common goals are well articulated and can be realized.

Encourage innovation and forward-thinking solutions.

Members

Shawn Novick
Q-RAD CMC Consulting

Kris Barnthouse
JnJ

Gerald Gellermann
Novartis

Elaine Gray
NIBSC

Melody Gossage
Lilly

Brendan Hughes
BMS

Juliana Kretsinger
Eli Lilly

Robert Mattaliano
Genzyme

Mourad Mellal
Catalent

John McKnight
Astrazeneca

Ned Mozier
Pfizer

Laura Pack
Rezolute

Joe Salazar
CSL Behring

Madhu Siluvera
Merck

Annie Sturgess
BMS

Michael Tarlov
NIST

John Ruesch
BioGen

Caroline Leveder
Sanofi

Nanda Subbarao
Biologics Consulting

Laura Viviani
Consultant

Committee Mission, Goals & Values

BT committee mission:
To find and promote science-based solutions to challenges which inhibit global access to critical biopharmaceuticals.

BT committee mission:

  • Identify and provide opportunities for researchers, industry, and regulators to address long standing and emerging issues which affect global access to biotherapeutics.
  • Provide organizational support for meetings where leaders can openly discuss challenges and share information, leading to potential solutions and sparking innovation.
  • Engage leaders working in the biopharmaceutical field and health care such that the paths to achieve common goals are well articulated and can be realized.
  • Encourage innovation and forward-thinking solutions

BT committee mission:

  • Members of the committee represent senior roles in industry and regulatory science*
  • Members identify barriers, new technologies, emerging issues, and unmet needs associated with biopharmaceuticals which affect global health and require further discussion, clarification, solutions, or dissemination to a broader community
  • Members provide leadership in developing workshops, discussion groups, or conferences where solutions, innovation, clarification, etc.. can be actuated.
  • Members take responsibility for attending quarterly meetings, bringing ideas, providing feedback, and participating on Scientific Organizing Committees of IABS events

    * Regulatory science is the scientific and technical foundations upon which regulations are based in the pharmaceutical industry.

IABS Values

  • Independence
  • Collaborative
  • Science-based
  • Credibility

Conferences and Workshop planning

To review IABS Biotherapeutics committee and workshops, click on the button below.

IABS UPCOMING EVENTS